Hypera (OTCMKTS:HYPMY) Sets New 52-Week Low – Should You Sell?

Hypera S.A. (OTCMKTS:HYPMY) shares reached a new 52-week low on Thursday . The stock traded as low as $3.06 and last traded at $3.09, with a volume of 49715 shares. The stock had previously closed at $3.20.

Hypera Price Performance

The company has a fifty day moving average of $3.98 and a two-hundred day moving average of $4.80. The stock has a market capitalization of $1.96 billion, a P/E ratio of 5.62 and a beta of 1.02.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.